Clene submits NDA to FDA for ALS drug CNM-Au8
Tweet Send to a Friend
Clene Inc. (Nasdaq: CLNN) announced it submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration earlier ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




